New York City-based biotech firm AXIM Biotechnologies creates products tailored for the medical marijuana industry.  The company has a particular interest in treating neurodegenerative diseases like multiple sclerosis (MS), Parkinson’s and Alzheimer’s diseases. Research shows certain cannabinoids have excellent anti-inflammatory… Continue Reading →